Vanguard Group Inc Ionis Pharmaceuticals Inc Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Vanguard Group Inc holds 13,430,456 shares of IONS stock, worth $505 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
13,430,456
Previous 14,203,481
5.44%
Holding current value
$505 Million
Previous $719 Million
18.97%
% of portfolio
0.01%
Previous 0.02%
Shares
12 transactions
Others Institutions Holding IONS
# of Institutions
396Shares Held
122MCall Options Held
854KPut Options Held
464K-
T. Rowe Price Investment Management, Inc. Baltimore, MD13.3MShares$500 Million0.35% of portfolio
-
Black Rock Inc. New York, NY9.77MShares$367 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V88.3MShares$312 Million5.64% of portfolio
-
Wellington Management Group LLP Boston, MA5.7MShares$214 Million0.04% of portfolio
-
Clearbridge Investments, LLC New York, NY4.47MShares$168 Million0.16% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.33B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...